Form 13-F position report

ODONATE THERAPEUTICS INC COM (

Reported by STATE STREET CORPORATION

ODT CUSIP 676079106 Manager CIK 0000093751

Reported 85,538 shares, down 17,865 (17.3%) from the prior quarter.

Reported value -61.8%; share count -17.3% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2021
Shares 85,538 Quarter-end amount reported
Reported value $115,000 Fair value at quarter end
Consecutive quarters held 16 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 115000
2022-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for ODONATE THERAPEUTICS INC COM ( held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2022 Reduced 0 -85,538 (-100.0%) 0 $0 2022-05-16
Q4 2021 Reduced 85,538 -17,865 (-17.3%) < 0.01% $115,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

67 managers reported ODONATE THERAPEUTICS INC COM ( for Q4 2021.

Managers reporting ODONATE THERAPEUTICS INC COM ( in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
TANG CAPITAL MANAGEMENT LLC Reduced 12,767,435 -2,747,131 3.47% $17,236,000 17 qtrs
Boxer Capital LLC Reduced 4,207,086 -1,400,000 0.22% $5,680,000 17 qtrs
Ikarian Capital LLC Reduced 1,340,631 -500,000 0.27% $1,810,000 4 qtrs
VANGUARD GROUP INC Added 964,818 +2,619 < 0.01% $1,302,000 17 qtrs
Samsara BioCapital LLC Unchanged 700,421 0 0.18% $946,000 13 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 416,739 +51,186 < 0.01% $561,000 4 qtrs
BlackRock Inc Reduced 400,914 -330,583 < 0.01% $541,000 16 qtrs
D E Shaw & Co Inc Added 374,195 +140,855 < 0.01% $505,000 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 352,814 +4,381 < 0.01% $476,000 16 qtrs
MYDA Advisors LLC Added 350,065 +260,091 0.13% $473,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
85,538
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.